Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progression

Biological Chemistry

Volumn 396, Issue 2, 2015, Pages 163-183

  Karagiannis, George S ^a,b   Musrap, Natasha ^a,b   Saraon, Punit ^a,b   Treacy, Ann ^c   Schaeffer, David F ^d   Kirsch, Richard ^b   Riddell, Robert H ^b   Diamandis, Eleftherios P ^a,b,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c Charlemont Clinic   (Ireland)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Angiogenesis; bone morphogenetic protein; cancer associated fibroblasts; colorectal cancer; epithelial to mesenchymal transition; gremlin 1; stroma; tumor microenvironment

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN ANTAGONIST GREMLIN 1; CADHERIN; LAMININ; LAMININ BETA 1; NERVE CELL ADHESION MOLECULE; OCCLUDIN; OSTEOGENIC PROTEIN 1; UNCLASSIFIED DRUG; UVOMORULIN; CKTSF1B1 PROTEIN, MOUSE; PROCOLLAGEN C PROTEINASE; SIGNAL PEPTIDE;

ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER CELL; CANCER GROWTH; CELL DIFFERENTIATION; CELL INTERACTION; CLINICAL ARTICLE; COLON CANCER; COLORECTAL CARCINOMA; COMPUTER MODEL; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; GENE EXPRESSION; HOST CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEOMICS; STROMA CELL; TUMOR HOST CELL INTERACTION; TUMOR INVASION; COLORECTAL TUMOR; DISEASE COURSE; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

GASTROPODA;

BONE MORPHOGENETIC PROTEIN 1; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; SIGNAL TRANSDUCTION;

EID: 84921369233     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2014-0221     Document Type: Article

References (104)

1. Ahmed, D., Eide, P.W., Eilertsen, I.A., Danielsen, S.A., Eknaes, M., Hektoen, M., Lind, G.E., and Lothe, R.A. (2013). Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis 2, e71.
2. Akcakaya, H., Aroymak, A., and Gokce, S. (2007). A. quantitative colorimetric method of measuring alkaline phosphatase activity in eukaryotic cell membranes. Cell. Biol. Int. 31, 186-190.
3. Alison, M.R., Lin, W.R., Lim, S.M., and Nicholson, L.J. (2012). Cancer stem cells: in the line of fire. Cancer Treat. Rev. 38, 589-598.
4. Bates, R.C. and Mercurio, A.M. (2005). The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol. Ther. 4, 365-370.
5. Beck, S.E., Jung, B.H., Fiorino, A., Gomez, J., Rosario, E.D., Cabrera, B.L., Huang, S.C., Chow, J.Y., and Carethers, J.M. (2006). Bone morphogenetic protein signaling and growth suppression in colon cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 291, G135-G145.
6. Beck, S.E., Jung, B.H., Del Rosario, E., Gomez, J., and Carethers, J.M. (2007). BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERK. Cell Signal. 19, 1465-1472.
7. Beites, C.L., Hollenbeck, P.L., Kim, J., Lovell-Badge, R., Lander, A.D., and Calof, A.L. (2009). Follistatin modulates a BMP autoregulatory loop to control the size and patterning of sensory domains in the developing tongue. Development 136, 2187-2197.
8. Bendtsen, J.D., Jensen, L.J., Blom, N., Von Heijne, G., and Brunak, S. (2004). Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng. Des. Sel. 17, 349-356.
9. Beppu, H., Mwizerwa, O.N., Beppu, Y., Dattwyler, M.P., Lauwers, G.Y., Bloch, K.D., and Goldstein, A.M. (2008). Stromal inactivation of BMPRII leads to colorectal epithelial overgrowth and polyp formation. Oncogene 27, 1063-1070.
10. Bertrand, F.E., Angus, C.W., Partis, W.J., and Sigounas, G. (2012). Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch. Cell Cycle 11, 4344-4351.
11. Bhowmick, N.A. and Moses, H.L. (2005). Tumor-stroma interactions. Curr. Opin. Genet. Dev. 15, 97-101.
12. Bissell, M.J. and Radisky, D. (2001). Putting tumours in context. Nat. Rev. Cancer 1, 46-54.
13. Boland, C.R. and Goel, A. (2010). Microsatellite instability in colorectal cancer. Gastroenterology 138, 2073-2087 e3.
14. Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., and Kirchner, T. (2005). Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat. Rev. Cancer 5, 744-749.
15. Cai, Z.G., Zhang, S.M., Zhang, H., Zhou, Y.Y., Wu, H.B., and Xu, X.P. (2013). Aberrant expression of microRNAs involved in epithelial-mesenchymal transition of HT-29 cell line. Cell. Biol. Int. 37, 669-674.
16. Chen, D., Zhao, M., and Mundy, G.R. (2004). Bone morphogenetic proteins. Growth Factors 22, 233-241.
17. Chen, M.H., Yeh, Y.C., Shyr, Y.M., Jan, Y.H., Chao, Y., Li, C.P., Wang, S.E., Tzeng, C.H., Chang, P.M., Liu, C.Y., et al. (2012). Expression of gremlin 1 correlates with increased angiogenesis and progression-free survival in patients with pancreatic neuroendocrine tumors. J. Gastroenterol. 48, 101-108.
18. Collier, T.S., Randall, S.M., Sarkar, P., Rao, B.M., Dean, R.A., and Muddiman, D.C. (2011). Comparison of stable-isotope labeling with amino acids in cell culture and spectral counting for relative quantification of protein expression. Rapid Commun. Mass Spectrom. 25, 2524-2532.
19. De Wever, O., Pauwels, P., De Craene, B., Sabbah, M., Emami, S., Redeuilh, G., Gespach, C., Bracke, M., and Berx, G. (2008). Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem. Cell Biol. 130, 481-494.
20. Deng, H., Makizumi, R., Ravikumar, T.S., Dong, H., Yang, W., and Yang, W.L. (2007a). Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells. Exp. Cell Res. 313, 1033-1044.
21. Deng, H., Ravikumar, T.S., and Yang, W.L. (2007b). Bone morphogenetic protein-4 inhibits heat-induced apoptosis by modulating MAPK pathways in human colon cancer HCT116 cells. Cancer Lett. 256, 207-217.
22. Deng, H., Ravikumar, T.S., and Yang, W.L. (2009). Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells. Cancer Lett. 281, 220-231.
23. Elenbaas, B. and Weinberg, R.A. (2001). Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res. 264, 169-184.
24. Gazzerro, E. and Canalis, E. (2006). Bone morphogenetic proteins and their antagonists. Rev. Endocr. Metab. Disord. 7, 51-65.
25. Goswami, C.P. and Nakshatri, H. (2013). PROGgene: gene expression based survival analysis web application for multiple cancers. J. Clin. Bioinforma 3, 22.
26. Grijelmo, C., Rodrigue, C., Svrcek, M., Bruyneel, E., Hendrix, A., de Wever, O., and Gespach, C. (2007). Proinvasive activity of BMP-7 through SMAD4/src-independent and ERK/Rac/JNK-dependent signaling pathways in colon cancer cells. Cell Signal. 19, 1722-1732.
27. Hanahan, D. and Weinberg, R.A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674.
28. Hardwick, J.C., Van Den Brink, G.R., Bleuming, S.A., Ballester, I., Van Den Brande, J.M., Keller, J.J., Offerhaus, G.J., Van Deventer, S.J., and Peppelenbosch, M.P. (2004). Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon. Gastroenterology 126, 111-121.
29. Hardwick, J.C., Kodach, L.L., Offerhaus, G.J., and van den Brink, G.R. (2008). Bone morphogenetic protein signalling in colorectal cancer. Nat. Rev. Cancer 8, 806-812.
30. He, X.C., Zhang, J., Tong, W.G., Tawfik, O., Ross, J., Scoville, D.H., Tian, Q., Zeng, X., He, X., Wiedemann, L.M., et al. (2004). BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-catenin signaling. Nat. Genet. 36, 1117-1121.
31. Hirakawa, M., Takimoto, R., Tamura, F., Yoshida, M., Ono, M., Murase, K., Sato, Y., Osuga, T., Sato, T., Iyama, S., et al. (2013). Fucosylated TGF-beta receptors transduces a signal for epithelial-mesenchymal transition in colorectal cancer cells. Br. J. Cancer 110, 156-163.
32. Ilyas, M., Straub, J., Tomlinson, I.P., and Bodmer, W.F. (1999). Genetic pathways in colorectal and other cancers. Eur. J. Cancer 35, 335-351.
33. Ishizuya-Oka, A. (2005). Epithelial-connective tissue cross-talk is essential for regeneration of intestinal epithelium. J. Nippon Med. Sch. 72, 13-18.
34. Jain, K.K. (2008). Innovations, challenges and future prospects of oncoproteomics. Mol. Oncol. 2, 153-160.
35. Kalluri, R. (2009). EMT: when epithelial cells decide to become mesenchymal-like cells. J. Clin. Invest. 119, 1417-1419.
36. Kalluri, R. and Weinberg, R.A. (2009). The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420-1428.
37. Kang, M.H., Kang, H.N., Kim, J.L., Kim, J.S., Oh, S.C., and Yoo, Y.A. (2009). Inhibition of PI3 kinase/Akt pathway is required for BMP2-induced EMT and invasion. Oncol. Rep. 22, 525-534.
38. Karagiannis, G.S., Pavlou, M.P., and Diamandis, E.P. (2010). Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology. Mol. Oncol. 4, 496-510.
39. Karagiannis, G.S., Petraki, C., Prassas, I., Saraon, P., Musrap, N., Dimitromanolakis, A., and Diamandis, E.P. (2012a). Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis. Oncotarget 3, 267-285.
40. Karagiannis, G.S., Poutahidis, T., Erdman, S.E., Kirsch, R., Riddell, R.H., and Diamandis, E.P. (2012b). Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue. Mol. Cancer Res. 10, 1403-1418.
41. Karagiannis, G.S., Berk, A., Dimitromanolakis, A., and Diamandis, E.P. (2013). Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1. Mol. Oncol. 7, 826-839.
42. Karagiannis, G.S., Schaeffer, D.F., Cho, C.K., Musrap, N., Saraon, P., Batruch, I., Grin, A., Mitrovic, B., Kirsch, R., Riddell, R.H., et al. (2014a). Collective migration of cancer-associated fibroblasts is enhanced by overexpression of tight junction-associated proteins claudin-11 and occludin. Mol. Oncol. 8, 178-195.
43. Karagiannis, G.S., Pavlou, M.P., Saraon, P., Musrap, N., Xie, A., Batruch, I., Prassas, I., Dimitromanolakis, A., Petraki, C., and Diamandis, E.P. (2014b). In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers. J. Proteomics 103, 121-136.
44. Karagiannis, G.S., Treacy, A., Messenger, D., Grin, A., Kirsch, R., Riddell, R.H., and Diamandis, E,P. (2014c) Expression patterns of bone morphogenetic protein antagonists in colorectal cancer desmoplastic invasion fronts. Mol. Oncol., in press.
45. Khokha, M.K., Hsu, D., Brunet, L.J., Dionne, M.S., and Harland, R.M. (2003). Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning. Nat. Genet. 34, 303-307.
46. Kishigami, S. and Mishina, Y. (2005). BMP signaling and early embryonic patterning. Cytokine Growth Factor Rev. 16, 265-278.
47. Kodach, L.L., Bleuming, S.A., Musler, A.R., Peppelenbosch, M.P., Hommes, D.W., van den Brink, G.R., van Noesel, C.J., Offerhaus, G.J., and Hardwick, J.C. (2008). The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer. Cancer 112, 300-306.
48. Kosinski, C., Li, V.S., Chan, A.S., Zhang, J., Ho, C., Tsui, W.Y., Chan, T.L., Mifflin, R.C., Powell, D.W., Yuen, S.T., et al. (2007). Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc. Natl. Acad. Sci. USA 104, 15418-15423.
49. Kukko, H.M., Koljonen, V.S., Tukiainen, E.J., Haglund, C.H., and Bohling, T.O. (2010). Vascular invasion is an early event in pathogenesis of Merkel cell carcinoma. Mod. Pathol. 23, 1151-1156.
50. Kulasingam, V. and Diamandis, E.P. (2008). Tissue culture-based breast cancer biomarker discovery platform. Int. J. Cancer 123, 2007-2012.
51. Kunz-Schughart, L.A. and Knuechel, R. (2002a). Tumor-associated fibroblasts (part I): Active stromal participants in tumor development and progression Histol. Histopathol. 17, 599-621.
52. Kunz-Schughart, L.A. and Knuechel, R. (2002b). Tumor-associated fibroblasts (part II): Functional impact on tumor tissue. Histol. Histopathol. 17, 623-637.
53. Lappin, D.W., McMahon, R., Murphy, M., and Brady, H.R. (2002). Gremlin: an example of the re-emergence of developmental programmes in diabetic nephropathy. Nephrol. Dial. Transplant 17 (Suppl 9), 65-67.
54. Li, Y., Zhu, X., Zeng, Y., Wang, J., Zhang, X., Ding, Y.Q., and Liang, L. (2010). FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition. Mol. Cancer Res. 8, 1579-1590.
55. Loboda, A., Nebozhyn, M.V., Watters, J.W., Buser, C.A., Shaw, P.M., Huang, P.S., Van't Veer, L., Tollenaar, R.A., Jackson, D.B., Agrawal, D., et al. (2011). EMT is the dominant program in human colon cancer. BMC Med. Genomics 4, 9.
56. Lorente-Trigos, A., Varnat, F., Melotti, A., and Ruiz i Altaba, A. (2010). BMP signaling promotes the growth of primary human colon carcinomas in vivo. J. Mol. Cell. Biol. 2, 318-332.
57. Markowitz, S.D. and Bertagnolli, M.M. (2009). Molecular origins of cancer: Molecular basis of colorectal cancer. N. Engl. J. Med. 361, 2449-2460.
58. Mezzano, S., Droguett, A., Burgos, M.E., Aros, C., Ardiles, L., Flores, C., Carpio, D., Carvajal, G., Ruiz-Ortega, M., and Egido, J. (2007). Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis. Nephrol. Dial. Transplant. 22, 1882-1890.
59. Michos, O., Panman, L., Vintersten, K., Beier, K., Zeller, R., and Zuniga, A. (2004). Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development 131, 3401-3410.
60. Michos, O., Goncalves, A., Lopez-Rios, J., Tiecke, E., Naillat, F., Beier, K., Galli, A., Vainio, S., and Zeller, R. (2007). Reduction of BMP4 activity by gremlin 1 enables ureteric bud outgrowth and GDNF/WNT11 feedback signalling during kidney branching morphogenesis. Development 134, 2397-2405.
61. Mitola, S., Ravelli, C., Moroni, E., Salvi, V., Leali, D., Ballmer-Hofer, K., Zammataro, L., and Presta, M. (2010). Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2. Blood 116, 3677-3680.
62. Mitrovic, B., Schaeffer, D.F., Riddell, R.H., and Kirsch, R. (2012). Tumor budding in colorectal carcinoma: time to take notice. Mod. Pathol. 25, 1315-1325.
63. Miyazono, K., Maeda, S., and Imamura, T. (2005). BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 16, 251-263.
64. Motoyama, K., Tanaka, F., Kosaka, Y., Mimori, K., Uetake, H., Inoue, H., Sugihara, K., and Mori, M. (2008). Clinical significance of BMP7 in human colorectal cancer. Ann. Surg. Oncol. 15, 1530-1537.
65. Mulvihill, M.S., Kwon, Y.W., Lee, S., Fang, L.T., Choi, H., Ray, R., Kang, H.C., Mao, J.H., Jablons, D., and Kim, I.J. (2012). Gremlin is overexpressed in lung adenocarcinoma and increases cell growth and proliferation in normal lung cells. PLoS One 7, e42264.
66. Murphy, M., McMahon, R., Lappin, D.W., and Brady, H.R. (2002). Gremlins: is this what renal fibrogenesis has come to Exp. Nephrol. 10, 241-244.
67. Myllärniemi, M., Lindholm, P., Ryynanen, M.J., Kliment, C.R., Salmenkivi, K., Keski-Oja, J., Kinnula, V.L., Oury, T.D., and Koli, K. (2008). Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 177, 321-329.
68. Navab, R., Strumpf, D., Bandarchi, B., Zhu, C.Q., Pintilie, M., Ramnarine, V.R., Ibrahimov, E., Radulovich, N., Leung, L., Barczyk, M., et al. (2011). Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. Proc. Natl. Acad. Sci. USA 108, 7160-7165.
69. Nishanian, T.G., Kim, J.S., Foxworth, A., and Waldman, T. (2004). Suppression of tumorigenesis and activation of Wnt signaling by bone morphogenetic protein 4 in human cancer cells. Cancer Biol. Ther. 3, 667-675.
70. Orimo, A., Gupta, P.B., Sgroi, D.C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V.J., Richardson, A.L., and Weinberg, R.A. (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348.
71. Owens, P., Pickup, M.W., Novitskiy, S.V., Chytil, A., Gorska, A.E., Aakre, M.E., West, J., and Moses, H.L. (2011) Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators. Proc. Natl. Acad. Sci. USA 109, 2814-2819.
72. Owens, P., Polikowsky, H., Pickup, M.W., Gorska, A.E., Jovanovic, B., Shaw, A.K., Novitskiy, S.V., Hong, C.C., and Moses, H.L. (2013). Bone Morphogenetic Proteins stimulate mammary fibroblasts to promote mammary carcinoma cell invasion. PLoS One 8, e67533.
73. Ravelli, C., Mitola, S., Corsini, M., and Presta, M. (2012). Involvement of alphavbeta3 integrin in gremlin-induced angiogenesis. Angiogenesis 16, 235-243.
74. Rooijens, P.P., de Krijger, R.R., Bonjer, H.J., van der Ham, F., Nigg, A.L., Bruining, H.A., Lamberts, S.W., and van der Harst, E. (2004). The significance of angiogenesis in malignant pheochromocytomas. Endocr. Pathol. 15, 39-45.
75. Roxburgh, S.A., Kattla, J.J., Curran, S.P., O'Meara, Y.M., Pollock, C.A., Goldschmeding, R., Godson, C., Martin, F., and Brazil, D.P. (2009). Allelic depletion of grem1 attenuates diabetic kidney disease. Diabetes 58, 1641-1650.
76. Saäf, A.M., Halbleib, J.M., Chen, X., Yuen, S.T., Leung, S.Y., Nelson, W.J., and Brown, P.O. (2007). Parallels between global transcriptional programs of polarizing Caco-2 intestinal epithelial cells in vitro and gene expression programs in normal colon and colon cancer. Mol. Biol. Cell 18, 4245-4260.
77. Saraon, P., Musrap, N., Cretu, D., Karagiannis, G.S., Batruch, I., Smith, C., Drabovich, A.P., Trudel, D., van der Kwast, T., Morrissey, C., et al. (2012). Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein, S. during the development of high grade and castration-resistant prostate cancer. J. Biol. Chem. 287, 34019-34031.
78. Saraon, P., Cretu, D., Musrap, N., Karagiannis, G.S., Batruch, I., Drabovich, A.P., van der Kwast, T., Mizokami, A., Morrissey, C., Jarvi, K., et al. (2013). Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression. Mol. Cell Proteomics 12, 1589-1601.
79. Scheel, C. and Weinberg, R.A. (2012). Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin. Cancer Biol. 22, 396-403.
80. Sell, S. (2010). On the stem cell origin of cancer. Am. J. Pathol 176, 2584-494.
81. Shen, L., Qu, X., Ma, Y., Zheng, J., Chu, D., Liu, B., Li, X., Wang, M., Xu, C., Liu, N., et al. (2014). Tumor suppressor NDRG2 tips the balance of oncogenic TGF-beta via EMT inhibition in colorectal cancer. Oncogenesis 3, e86.
82. Slattery, M.L., Lundgreen, A., Herrick, J.S., Kadlubar, S., Caan, B.J., Potter, J.D., and Wolff, R.K. (2011a). Genetic variation in bone morphogenetic protein and colon and rectal cancer. Int. J. Cancer 130, 653-664.
83. Slattery, M.L., Lundgreen, A., Herrick, J.S., Wolff, R.K., and Caan, B.J. (2011b). Genetic variation in the transforming growth factorbeta signaling pathway and survival after diagnosis with colon and rectal cancer. Cancer 117, 4175-4183.
84. Smith, J.J., Deane, N.G., Wu, F., Merchant, N.B., Zhang, B., Jiang, A., Lu, P., Johnson, J.C., Schmidt, C., Bailey, C.E., et al. (2009). Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 138, 958-968.
85. Sneddon, J.B. (2009). The contribution of niche-derived factors to the regulation of cancer cells. Methods Mol. Biol. 568, 217-232.
86. Sneddon, J.B. and Werb, Z. (2007). Location, location, location: the cancer stem cell niche. Cell Stem Cell 1, 607-611.
87. Sneddon, J.B., Zhen, H.H., Montgomery, K., van de Rijn, M., Tward, A.D., West, R., Gladstone, H., Chang, H.Y., Morganroth, G.S., Oro, A.E., et al. (2006). Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc. Natl. Acad. Sci. USA 103, 14842-14847.
88. Souvannavong, V., Lemaire, C., De Nay, D., Brown, S., and Adam, A. (1995). Expression of alkaline phosphatase by a B-cell hybridoma and its modulation during cell growth and apoptosis. Immunol. Lett. 47, 163-170.
89. Spaderna, S., Schmalhofer, O., Hlubek, F., Jung, A., Kirchner, T., and Brabletz, T. (2007). Epithelial-mesenchymal and mesenchymalepithelial transitions during cancer progression. Verh. Dtsch. Ges. Pathol. 91, 21-28.
90. Stabile, H., Mitola, S., Moroni, E., Belleri, M., Nicoli, S., Coltrini, D., Peri, F., Pessi, A., Orsatti, L., Talamo, F., et al. (2007). Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. Blood 109, 1834-1840.
91. Sugino, T., Kusakabe, T., Hoshi, N., Yamaguchi, T., Kawaguchi, T., Goodison, S., Sekimata, M., Homma, Y., and Suzuki, T. (2002). An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model. Am. J. Pathol. 160, 1973-1980.
92. Sugino, T., Yamaguchi, T., Ogura, G., Saito, A., Hashimoto, T., Hoshi, N., Yoshida, S., Goodison, S., and Suzuki, T. (2004). Morphological evidence for an invasion-independent metastasis pathway exists in multiple human cancers. BMC Med. 2, 9.
93. Tse, J.C. and Kalluri, R. (2007). Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J. Cell. Biochem. 101, 816-829.
94. von Bubnoff, A. and Cho, K.W. (2001). Intracellular BMP signaling regulation in vertebrates: pathway or network Dev. Biol. 239, 1-14.
95. von Kleist, S., Chany, E., Burtin, P., King, M., and Fogh, J. (1975). Immunohistology of the antigenic pattern of a continuous cell line from a human colon tumor. J. Natl. Cancer Inst. 55, 555-560.
96. Watnick, R.S. (2012). The role of the tumor microenvironment in regulating angiogenesis. Cold Spring Harb. Perspect. Med. 2, a006676.
97. Weiss, L. and Ward, P.M. (1983). Cell detachment and metastasis. Cancer Metastasis Rev. 2, 111-127.
98. Werfel, J., Krause, S., Bischof, A.G., Mannix, R.J., Tobin, H., Bar-Yam, Y., Bellin, R.M., and Ingber, D.E. (2013). How changes in extracellular matrix mechanics and gene expression variability might combine to drive cancer progression. PLoS One 8, e76122.
99. Wu, W.K., Sung, J.J., Wu, Y.C., Li, Z.J., Yu, L., and Cho, C.H. (2008). Bone morphogenetic protein signalling is required for the antimitogenic effect of the proteasome inhibitor MG-132 on colon cancer cells. Br. J. Pharmacol. 154, 632-638.
100. Xu, R.H., Peck, R.M., Li, D.S., Feng, X., Ludwig, T., and Thomson, J.A. (2005). Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human, E.S. cells. Nat. Methods 2, 185-190.
101. Yan, K., Wu, Q., Yan, D.H., Lee, C.H., Rahim, N., Tritschler, I., DeVecchio, J., Kalady, M.F., Hjelmeland, A.B., Rich, J.N. (2014). Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy. Genes Dev. 28, 1085-1100.
102. Zeisberg, E.M., Potenta, S., Xie, L., Zeisberg, M., and Kalluri, R. (2007). Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 67, 10123-10128.
103. Zhang, J.F., Fu, W.M., He, M.L., Xie, W.D., Lv, Q., Wan, G., Li, G., Wang, H., Lu, G., Hu, X., et al. (2011). MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling. RNA Biol. 8, 829-838.
104. Zlobec, I. and Lugli, A. (2011). Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget 1, 651-661.